tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
Holding TCRX?
Track your performance easily

TScan Therapeutics (TCRX) Financial Statements

180 Followers

TScan Therapeutics Financial Overview

TScan Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.249; its P/E ratio is -4.56; TScan Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.05M$ 536.00K$ 566.00K$ 7.21M$ 3.89M
Gross Profit$ 1.05M$ 536.00K$ 566.00K$ 7.21M$ 3.89M
EBIT$ -28.93M$ -30.71M$ -29.18M$ -18.76M$ -22.02M
EBITDA$ -27.90M$ -29.59M$ -27.93M$ -17.48M$ -20.73M
Net Income Common Stockholders$ -29.89M$ -31.66M$ -30.14M$ -19.61M$ -23.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 271.12M$ 297.68M$ 162.78M$ 192.04M$ 215.42M
Total Assets$ 348.03M$ 374.87M$ 240.83M$ 272.15M$ 291.38M
Total Debt$ 90.36M$ 91.07M$ 91.76M$ 92.43M$ 86.98M
Net Debt$ -180.76M$ -206.60M$ -71.02M$ -99.61M$ -128.44M
Total Liabilities$ 118.94M$ 119.65M$ 117.86M$ 121.28M$ 122.42M
Stockholders Equity$ 229.09M$ 255.22M$ 122.97M$ 150.87M$ 168.96M
Cash Flow-
Free Cash Flow$ -29.29M$ -27.09M$ -29.97M$ -24.23M$ 6.60M
Operating Cash Flow$ -27.92M$ -26.23M$ -29.27M$ -23.77M$ 8.02M
Investing Cash Flow$ -82.35M$ -33.72M$ 36.16M$ 1.91M$ -61.41M
Financing Cash Flow$ 1.23M$ 161.59M$ 258.00K$ 19.00K$ -252.00K
Currency in USD

TScan Therapeutics Earnings and Revenue History

TScan Therapeutics Debt to Assets

TScan Therapeutics Cash Flow

TScan Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis